Перейти к содержанию

Tandem Diabetes Care Inc (TNDM) stock: revenue, earnings & dividend

Tandem Diabetes Care Inc (TNDM, Nasdaq): revenue, earnings, dividend and balance sheet from official SEC filings.

Stock screener TNDM · Nasdaq Medizintechnik & Messgeräte US-CA

Key figures

Fiscal year
2025
Revenue
1.01 bn $
Revenue growth
7.9 %
Revenue growth 5y (p.a.)
15.3 %
Net income
-204.7 m $
Net margin
-20.2 %
Operating margin
-18.5 %
Earnings per share (diluted)
-3.04 $
Dividend per share
–
Payout ratio
–
Consecutive dividend years
–
Consecutive dividend raises
–
Dividend growth 5y (p.a.)
–
Total assets
881 m $
Equity
155 m $
Equity ratio
17.6 %
Return on equity
-131.9 %
Cash
90.6 m $
Operating cash flow
-9.72 m $
Free cash flow
-29.67 m $
Shares outstanding
69,793,846

History

Revenue by fiscal year

2016 84.2 m $
2017 108 m $
2018 184 m $
2019 362 m $
2020 499 m $
2021 703 m $
2022 801 m $
2023 748 m $
2024 940 m $
2025 1.01 bn $

Net income by fiscal year

2016 -83.45 m $
2017 -73.03 m $
2018 -122.61 m $
2019 -24.75 m $
2020 -34.38 m $
2021 15.6 m $
2022 -94.6 m $
2023 -222.6 m $
2024 -96 m $
2025 -204.7 m $
YearRevenueNet incomeEPSDividend per shareOperating cash flow
20251.01 bn $-204.7 m $-3.04 $–-9.72 m $
2024940 m $-96 m $-1.47 $–24.2 m $
2023748 m $-222.6 m $-3.43 $–-31.81 m $
2022801 m $-94.6 m $-1.47 $–50.5 m $
2021703 m $15.6 m $0.24 $–111 m $
2020499 m $-34.38 m $-0.56 $–24.7 m $
2019362 m $-24.75 m $-0.42 $–41.9 m $
2018184 m $-122.61 m $––-8.32 m $
2017108 m $-73.03 m $––-66.14 m $
201684.2 m $-83.45 m $––-61.17 m $

Data from XBRL filings at the SEC, processed automatically, no guarantee. Not investment advice. All filings at the SEC (EDGAR)